Minimal phenotyping yields GWAS hits of low specificity for major depression
Cai, N.; A. Revez, J. A.; Adams, M. J.; Andlauer, T. F. M.; Breen, G.; Byrne, E. M.; Clarke, T.-K.; Forstner, A. J. J.; Grabe, H. J. J.; Hamilton, S. P.; Levinson, D. F.; Lewis, C. M.; Lewis, G.; Martin, N. G.; Milaneschi, Y.; Mors, O.; Muller-Myhsok, B.; Penninx, B. W. W. J. H.; Perlis, R. H.; Pistis, G.; Potash, J. B.; Preisig, M.; Shi, J.; Smoller, J. W.; Streit, F.; Tiemeier, H.; Uher, R.; Van der Auwera, S.; Viktorin, A.; Weissman, M. M.; MDD Working Group of the Psychiatric Genomics Cons, ; Kendler, K. S.; Flint, J.
Show abstract
Minimal phenotyping refers to the reliance on the use of a small number of self-report items for disease case identification. This strategy has been applied to genome-wide association studies (GWAS) of major depressive disorder (MDD). Here we report that the genotype derived heritability (h2SNP) of depression defined by minimal phenotyping (14%, SE = 0.8%) is lower than strictly defined MDD (26%, SE = 2.2%). This cannot be explained by differences in prevalence between definitions or including cases of lower liability to MDD in minimal phenotyping definitions of depression, but can be explained by misdiagnosis of those without depression or with related conditions as cases of depression. Depression defined by minimal phenotyping is as genetically correlated with strictly defined MDD (rG = 0.81, SE = 0.03) as it is with the personality trait neuroticism (rG = 0.84, SE = 0.05), a trait not defined by the cardinal symptoms of depression. While they both show similar shared genetic liability with neuroticism, a greater proportion of the genome contributes to the minimal phenotyping definitions of depression (80.2%, SE = 0.6%) than to strictly defined MDD (65.8%, SE = 0.6%). We find that GWAS loci identified in minimal phenotyping definitions of depression are not specific to MDD: they also predispose to other psychiatric conditions. Finally, while highly predictive polygenic risk scores can be generated from minimal phenotyping definitions of MDD, the predictive power can be explained entirely by the sample size used to generate the polygenic risk score, rather than specificity for MDD. Our results reveal that genetic analysis of minimal phenotyping definitions of depression identifies non-specific genetic factors shared between MDD and other psychiatric conditions. Reliance on results from minimal phenotyping for MDD may thus bias views of the genetic architecture of MDD and may impede our ability to identify pathways specific to MDD.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder 96%
- Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology 96%
- Differential Chromatin Architecture and Risk Variants in Deep Layer Excitatory Neurons and Grey Matter Microglia Contribute to Major Depressive Disorder 95%
Similar papers in this journal
- Polygenic analyses show important differences between MDD symptoms collected using PHQ9 and CIDI-SF 98%
- The genetics of the mood disorder spectrum: genome-wide association analyses of over 185,000 cases and 439,000 controls 96%
- GWAS of Over 427,000 Individuals Establishes GABAergic and Synaptic Molecular Pathways as Key for Cognitive Executive Functions 95%
Similar papers in this journal
- Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression 94%
- Indecision and recency-weighted evidence integration in non-clinical and clinical settings 93%
- Genetic Underpinnings of Risky Behaviour Relate to Altered Neuroanatomy 93%
Similar papers in this journal
- Decoding shared versus divergent transcriptomic signatures across cortico-amygdala circuitry in PTSD and depressive disorders 95%
- Reproducible Risk Loci and Psychiatric Comorbidities in Anxiety: Results from ~200,000 Million Veteran Program Participants 94%
- Multivariate GWAS elucidates the genetic architecture of alcohol consumption and misuse, corrects biases, and reveals novel associations with disease 92%
Similar papers in this journal
- Functional and molecular characterization of suicidality factors using phenotypic and genome-wide data 95%
- Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions 95%
- Predicting Substance Use Disorders: A Multifactorial Risk Index Combining Clinical, Environmental, and Genetic Risk Factors 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.